Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.
about
Integrated therapy for HIV and tuberculosisInitiating antiretrovirals during tuberculosis treatment: a drug safety review.TB and HIV Therapeutics: Pharmacology Research Priorities.Effect of anti-tuberculosis therapy on polymorphic drug metabolizing enzyme CYP2C9 using phenytoin as a probe drug.Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.Atazanavir: its role in HIV treatmentClinical pharmacology, efficacy and safety of atazanavir: a review.Rifampin combination therapy for nonmycobacterial infections.Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis.P-glycoprotein related drug interactions: clinical importance and a consideration of disease states.Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.Addressing Antiretroviral Therapy-Associated Drug-Drug Interactions in Patients Requiring Treatment for Opportunistic Infections in Low-Income and Resource-Limited Settings.British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q26749428-972FF11C-D066-4758-A258-8191965913D5Q35043048-A651395D-11BA-4485-88CB-6796FC1CF5B9Q36099838-6841C74B-1779-4A94-950A-77F6AF5FB468Q36313485-AA49A707-283C-4415-A72A-5F8CA376299AQ37121902-DA3AFF72-93B0-4DE4-A36E-D2FBACE01730Q37249418-251319DB-006C-4023-83E9-5334D17BF133Q37622972-1FC9A03A-95EE-45A2-8E63-688358C4AB46Q37672039-46277099-C16E-42DF-A1EB-789C5A1B16A5Q37711305-86B9CD39-BCF4-4EAB-945D-4343B53AE1F1Q37732337-25CE388D-9007-4523-92B3-68C560B4B4A1Q38030981-3CCF80A2-EA78-4B4B-AE36-42D7CDB8AB34Q40051462-D888CAB0-44BD-4FCF-9BC9-859BBE94E80DQ57180790-42765C9A-C6DD-45CF-BD67-B6E19AB08BAE
P2860
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effect of concomitantly admini ...... avir administered twice daily.
@ast
Effect of concomitantly admini ...... avir administered twice daily.
@en
type
label
Effect of concomitantly admini ...... avir administered twice daily.
@ast
Effect of concomitantly admini ...... avir administered twice daily.
@en
prefLabel
Effect of concomitantly admini ...... avir administered twice daily.
@ast
Effect of concomitantly admini ...... avir administered twice daily.
@en
P2093
P2860
P356
P1476
Effect of concomitantly admini ...... avir administered twice daily.
@en
P2093
Andrew R Zolopa
Beverly Alston-Smith
David W Haas
Edward P Acosta
John G Gerber
Lara Hosey
Michael Child
Michelle A Kendall
Richard Bertz
Sangeeta Agarwala
P2860
P304
P356
10.1128/AAC.00341-07
P407
P577
2007-06-18T00:00:00Z